Oxidative phosphorylation (OXPHOS) is a vital process for energy generation, and is carried out by complexes within the mitochondria. OXPHOS complexes pose a unique challenge for cells because their subunits are encoded on both the nuclear and the mitochondrial genomes. Genomic approaches designed to study nuclear/cytosolic and bacterial gene expression have not been broadly applied to mitochondria, so the co-regulation of OXPHOS genes remains largely unexplored. Here we monitor mitochondrial and nuclear gene expression in Saccharomyces cerevisiae during mitochondrial biogenesis, when OXPHOS complexes are synthesized. We show that nuclear- and mitochondrial-encoded OXPHOS transcript levels do not increase concordantly. Instead, mitochondrial and cytosolic translation are rapidly, dynamically and synchronously regulated. Furthermore, cytosolic translation processes control mitochondrial translation unidirectionally. Thus, the nuclear genome coordinates mitochondrial and cytosolic translation to orchestrate the timely synthesis of OXPHOS complexes, representing an unappreciated regulatory layer shaping the mitochondrial proteome. Our whole-cell genomic profiling approach establishes a foundation for studies of global gene regulation in mitochondria.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Masters, B. S., Stohl, L. L. & Clayton, D. A. Yeast mitochondrial RNA polymerase is homologous to those encoded by bacteriophages T3 and T7. Cell 51, 89–99 (1987)
Faye, G. & Sor, F. Analysis of mitochondrial ribosomal proteins of Saccharomyces cerevisiae by two dimensional polyacrylamide gel electrophoresis. Mol. Gen. Genet. 155, 27–34 (1977)
Kehrein, K., Bonnefoy, N. & Ott, M. Mitochondrial protein synthesis: efficiency and accuracy. Antioxid. Redox Signal. 19, 1928–1939 (2013)
Bonitz, S. G. et al. Codon recognition rules in yeast mitochondria. Proc. Natl Acad. Sci. USA 77, 3167–3170 (1980)
Costanzo, M. C. & Fox, T. D. Control of mitochondrial gene expression in Saccharomyces cerevisiae . Annu. Rev. Genet. 24, 91–113 (1990)
Green-Willms, N. S., Butler, C. A., Dunstan, H. M. & Fox, T. D. Pet111p, an inner membrane-bound translational activator that limits expression of the Saccharomyces cerevisiae mitochondrial gene COX2. J. Biol. Chem. 276, 6392–6397 (2001)
Herrmann, J. M., Woellhaf, M. W. & Bonnefoy, N. Control of protein synthesis in yeast mitochondria: the concept of translational activators. Biochim. Biophys. Acta 1833, 286–294 (2013)
Müller, P. P. et al. A nuclear mutation that post-transcriptionally blocks accumulation of a yeast mitochondrial gene product can be suppressed by a mitochondrial gene rearrangement. J. Mol. Biol. 175, 431–452 (1984)
Fraenkel, D. G. Yeast Intermediary Metabolism (Cold Spring Harbor Press, 2011)
Kuhn, K. M., DeRisi, J. L., Brown, P. O. & Sarnow, P. Global and specific translational regulation in the genomic response of Saccharomyces cerevisiae to a rapid transfer from a fermentable to a nonfermentable carbon source. Mol. Cell. Biol. 21, 916–927 (2001)
Amiott, E. A. & Jaehning, J. A. Mitochondrial transcription is regulated via an ATP “sensing” mechanism that couples RNA abundance to respiration. Mol. Cell 22, 329–338 (2006)
Mueller, D. M. & Getz, G. S. Steady state analysis of mitochondrial RNA after growth of yeast Saccharomyces cerevisiae under catabolite repression and derepression. J. Biol. Chem. 261, 11816–11822 (1986)
DeRisi, J. L., Iyer, V. R. & Brown, P. O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680–686 (1997)
Roberts, G. G. & Hudson, A. P. Transcriptome profiling of Saccharomyces cerevisiae during a transition from fermentative to glycerol-based respiratory growth reveals extensive metabolic and structural remodeling. Mol. Genet. Genomics 276, 170–186 (2006)
Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863–14868 (1998)
Fox, T. D. et al. Analysis and manipulation of yeast mitochondrial genes. Methods Enzymol. 194, 149–165 (1991)
Ashe, M. P., De Long, S. K. & Sachs, A. B. Glucose depletion rapidly inhibits translation initiation in yeast. Mol. Biol. Cell 11, 833–848 (2000)
Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. & Weissman, J. S. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324, 218–223 (2009)
Rooijers, K., Loayza-Puch, F., Nijtmans, L. G. & Agami, R. Ribosome profiling reveals features of normal and disease-associated mitochondrial translation. Nature Commun. 4, 2886 (2013)
Vignais, P. V., Stevens, B. J., Huet, J. & Andre, J. Mitoribosomes from Candida utilis. Morphological, physical, and chemical characterization of the monomer form and of its subunits. J. Cell Biol. 54, 468–492 (1972)
Wolin, S. L. & Walter, P. Ribosome pausing and stacking during translation of a eukaryotic mRNA. EMBO J. 7, 3559–3569 (1988)
Poutre, C. G. & Fox, T. D. PET111, a Saccharomyces cerevisiae nuclear gene required for translation of the mitochondrial mRNA encoding cytochrome c oxidase subunit II. Genetics 115, 637–647 (1987)
Simpson, C. E. & Ashe, M. P. Adaptation to stress in yeast: to translate or not? Biochem. Soc. Trans. 40, 794–799 (2012)
Poyton, R. O., Bellus, G., McKee, E. E., Sevarino, K. A. & Goehring, B. In organello mitochondrial protein and RNA synthesis systems from Saccharomyces cerevisiae . Methods Enzymol. 264, 36–42 (1996)
Lamb, A. J., Clark-Walker, G. D. & Linnane, A. W. The biogenesis of mitochondria. 4. The differentiation of mitochondrial and cytoplasmic protein synthesizing systems in vitro by antibiotics. Biochim. Biophys. Acta 161, 415–427 (1968)
Rak, M. et al. Regulation of mitochondrial translation of the ATP8/ATP6 mRNA by Smt1p. Mol. Biol. Cell (2016)
Sun, T. & Zhang, Y. Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation. Nucleic Acids Res. 36, 1654–1664 (2008)
Zhang, Y., Bell, A., Perlman, P. S. & Leibowitz, M. J. Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae . RNA 6, 937–951 (2000)
Liu, B. & Qian, S. B. Translational reprogramming in cellular stress response. Wiley Interdiscip. Rev. RNA 5, 301–315 (2014)
Pavlov, M. Y. & Ehrenberg, M. Optimal control of gene expression for fast proteome adaptation to environmental change. Proc. Natl Acad. Sci. USA 110, 20527–20532 (2013)
Sonenberg, N. & Hinnebusch, A. G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136, 731–745 (2009)
Gruschke, S. et al. The Cbp3-Cbp6 complex coordinates cytochrome b synthesis with bc 1 complex assembly in yeast mitochondria. J. Cell Biol. 199, 137–150 (2012)
Perez-Martinez, X., Butler, C. A., Shingu-Vazquez, M. & Fox, T. D. Dual functions of Mss51 couple synthesis of Cox1 to assembly of cytochrome c oxidase in Saccharomyces cerevisiae mitochondria. Mol. Biol. Cell 20, 4371–4380 (2009)
Ehrenreich, I. M. et al. Dissection of genetically complex traits with extremely large pools of yeast segregants. Nature 464, 1039–1042 (2010)
Gaisne, M., Becam, A. M., Verdiere, J. & Herbert, C. J. A ‘natural’ mutation in Saccharomyces cerevisiae strains derived from S288c affects the complex regulatory gene HAP1 (CYP1). Curr. Genet. 36, 195–200 (1999)
Baruffini, E., Lodi, T., Dallabona, C. & Foury, F. A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability. Genetics 177, 1227–1231 (2007)
Young, M. J. & Court, D. A. Effects of the S288c genetic background and common auxotrophic markers on mitochondrial DNA function in Saccharomyces cerevisiae . Yeast 25, 903–912 (2008)
Alani, E., Cao, L. & Kleckner, N. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 116, 541–545 (1987)
Moqtaderi, Z. & Struhl, K. Expanding the repertoire of plasmids for PCR-mediated epitope tagging in yeast. Yeast 25, 287–292 (2008)
Storici, F. & Resnick, M. A. The delitto perfetto approach to in vivo site-directed mutagenesis and chromosome rearrangements with synthetic oligonucleotides in yeast. Methods Enzymol. 409, 329–345 (2006)
Dimitrov, L. N., Brem, R. B., Kruglyak, L. & Gottschling, D. E. Polymorphisms in multiple genes contribute to the spontaneous mitochondrial genome instability of Saccharomyces cerevisiae S288C strains. Genetics 183, 365–383 (2009)
Gouget, K., Verde, F. & Barrientos, A. In vivo labeling and analysis of mitochondrial translation products in budding and in fission yeasts. Methods Mol. Biol. 457, 113–124 (2008)
Ingolia, N. T., Brar, G. A., Rouskin, S., McGeachy, A. M. & Weissman, J. S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nature Protocols 7, 1534–1550 (2012)
Brar, G. A. et al. High-resolution view of the yeast meiotic program revealed by ribosome profiling. Science 335, 552–557 (2012)
Ingolia, N. T. Genome-wide translational profiling by ribosome footprinting. Methods Enzymol. 470, 119–142 (2010)
Martin, M. Cutadapt removes adaptor sequences from high-throughput sequencing reads. EMBnet.journal 17, 10–12 (2011)
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009)
Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013)
Li, G. W., Burkhardt, D., Gross, C. & Weissman, J. S. Quantifying absolute protein synthesis rates reveals principles underlying allocation of cellular resources. Cell 157, 624–635 (2014)
We thank F. Winston, T. Fox, G. Brar and members of the Churchman lab for advice and discussions; members of the O’Shea, Novina, and Springer labs for use of equipment and advice; and M. Hickman and D. Botstein for sharing the HAP1+ strain. Research supported by a Damon Runyon Cancer Research Foundation Frey Award (to L.S.C.), a Burroughs Wellcome Fund Career Award at the Scientific Interface (to L.S.C.), an Ellison Medical Foundation New Scholar in Aging Award (to L.S.C.), the National Institutes of Health F32 (to M.T.C.), and a Boehringer Ingelheim Fonds PhD Fellowship (to G.S.).
The authors declare no competing financial interests.
Reviewer Information Nature thanks P. Van Damme and the other anonymous reviewer(s) for their contribution to the peer review of this work.
Extended data figures and tables
Western blot analysis of mitochondrial (Cob, Cox1, Cox2) and nuclear (Cox4) OXPHOS proteins compared to Flag-tagged mitoribosome small subunit protein MrpS17. Gapdh was used as a loading control. For gel source data, see Supplementary Fig. 1.
a–c, RNA levels (reads per kb) normalized to spike-in controls and plotted as fold changes compared to levels in log phase glucose growth for all nuclear-encoded structural components of the complexes shown (a); intron-encoded maturases (b); and nuclear and mitochondrial-encoded mitoribosome subunits (c). To calculate values for maturase transcripts, only reads not overlapping the main ORF (COX1 or COB) were considered. Group II intron splicing intermediates stably accumulate and may not represent translation-competent transcripts.
a, Serial dilution spot tests verifying tagged mitoribosome subunits are functional as they support respiratory growth on glycerol (YPG). ρ0 is a strain without mitochondrial DNA. b, Frequency of petite colonies in our corrected S288c strain (see Methods) after growth for 5 days on 0.1% glucose and 3% glycerol. BY4742 is S288c background with designer auxotrophies. Σ1278b is a strain with wild-type HAP1, and a high-fidelity allele of MIP1, MIP1[Σ], along with other differences compared to S288c. Error bars show variation due to counting, with 175–750 colonies counted for each sample. c, Lysis and immunoprecipitation buffer conditions affect mitoribosome subunit association and thus footprint retention. Left: silver staining after immunoprecipitation of the large subunit (LSU) with Mrp20–Flag and of the small subunit (SSU) with Mrps17–Flag in condition 1 (20 mM Tris pH 8.0, 200 mM KCl, 5 mM MgCl2, 0.5% lauryl maltoside), and in condition 2 (10 mM Tris pH 8.0, 50 mM NH4Cl, 10 mM MgCl2, 0.5% lauryl maltoside). Arrowheads indicate bands that appear in both immunoprecipitations in condition 2 that can be assigned to the LSU or SSU by comparison to condition 1. Asterisks mark the expected mobility of the tagged proteins. Right: northern blotting of the co-purifying RNA in each condition. For gel source data, see Supplementary Fig. 1. d, Western blot showing fractions from immunoprecipitation using optimized buffer conditions. Flag immunoprecipitation targeting the mitoribosome SSU co-purifies a haemagglutinin (HA)-tagged LSU protein. For gel source data, see Supplementary Fig. 1.
Extended Data Figure 4 Mitoribosome profiling is robust, reproducible, and does not require translation inhibitors.
a, Mapping statistics for representative mitoribosome and cytoribosome profiling libraries from log phase glycerol-grown cells. b, Fraction of reads mapping to each frame of mitochondrial ORFs (left) and nuclear ORFs (right) in mitoribosome profiling and cytoribosome profiling data, respectively. RNA-seq reads in the left panel were treated identically to footprint reads, including size selection for library generation. c, Reproducibility between biological replicates. Each dot corresponds to the number of reads mapped to a particular position on mRNA (RPM, left), or summed number of reads mapped across each mRNA then normalized to length (RPKM, right). d, Reproducibility with and without translation inhibitors thiamphenicol (50 μg ml−1) and GTP analogue GMPPNP (1 mM).
Extended Data Figure 5 Mitochondrial and cytosolic protein synthesis on OXPHOS mRNAs is rapidly regulated.
a, b, Fold changes in relative protein synthesis (footprint RPKM values) compared to log phase glucose growth for the OXPHOS subunits synthesized in mitochondria (a; values are means of two experiments) and cytosol (b). Asterisks on heat maps indicate the subunits shown in the line plots.
Fold change data identical to those shown in Fig. 3a, but including range bars for two experiments performed from independent cultures on different days (left), and fold change translation efficiency data plotted as a scatter with the Pearson correlation coefficient (right). Dotted lines mark twofold difference. RNA-seq data used in calculating translation efficiency are from a single experiment.
Polysome profiles from samples used for cytoribosome profiling, but without RNase I treatment. Gradients were loaded with lysate from equal cell numbers, allowing overall ribosome abundances to be compared between samples. Doubling time during log phase is ~1.2 h in glucose and ~3.7 h in glycerol.
a, FACS analysis of yeast cultures treated with CCCP. Wild-type cultures were grown in glucose to mid-log phase and treated with 40 μM CCCP for the indicated times. Mitochondrial membrane potential (ΔΨm) was assessed using 1 μM tetramethylrhodamine (TMRM), which is taken up by only a fraction of the cell population (17.9% in this experiment). TMRM accumulates inside negatively charged mitochondria, producing increased fluorescence intensity (102). Loss of membrane potential dissipates probe, measured as loss of high-intensity fluorescence. b, Representative northern blots for data in Fig. 4b, c and panel e. For quantification, northern signals were normalized by relative mitoribosome recovery measured by Mrps17–Flag signal in western blots. For gel source data, see Supplementary Fig. 1. c, Northern blotting of total RNA for the indicated transcripts. For gel source data, see Supplementary Fig. 1. d, Quantification of viability assay. Cells were grown in YPD (Glu) or YPG (Gly) with or without drug for the time indicated. Cells were washed out of drug and plated on YPD for calculation of colony-forming units. CCCP (40 μM); CHX (100 μg ml−1); pentamidine (Pent; 10 μM). e, Mitochondrial translation response to inhibition of mitochondrial import with CCCP, measured by northern blotting for footprints (see b). f, Fold change in synthesis measured by cytoribosome profiling of nuclear-encoded mitochondrial mRNA-specific translational activators (colour-coded by mRNA target). For each mitochondrial mRNA, the names of the known translational activators are listed. Source data
Extended Data Figure 9 Cytosolic OXPHOS translation response is independent of mitochondrial gene expression.
a, Metabolic labelling to measure mitochondrial translation (Mito Tln), detectable only in the presence of CHX, and cytosolic translation (Cyto Tln). Samples generated in the absence of CHX were diluted 15-fold before loading the gel compared to samples generated with CHX. Mitochondrial translation products are labelled. b, c, Full data set for experiment presented in Fig. 4d, e, showing fold changes in translation efficiency of all nuclear-encoded complex III, complex IV, and ATP synthase subunits measured by cytoribosome profiling without (−Pent) or with (+Pent) inhibition of mitochondrial translation (b) and in ρ0 cells (c), which have neither mitochondrial translation nor functional OXPHOS complexes.
a, Spot tests verifying that the ρ0 strain generated by overnight growth in ethidium bromide (see Methods) cannot respire (no growth on YPG). b, PCR (left) and qPCR (right) verifying loss of mitochondrial-encoded genes COX1, COX3, and the 21S mitochondrial rRNA gene. MRPS17 is nuclear-encoded. Bars show s.e.m. for technical triplicates.
About this article
Cite this article
Couvillion, M., Soto, I., Shipkovenska, G. et al. Synchronized mitochondrial and cytosolic translation programs. Nature 533, 499–503 (2016). https://doi.org/10.1038/nature18015
Nature Reviews Molecular Cell Biology (2021)
Molecular Metabolism (2020)
Mitochondrial volume fraction and translation duration impact mitochondrial mRNA localization and protein synthesis
Human Genetics (2020)
Mitochondrial dysfunction and DNA damage accompany enhanced levels of formaldehyde in cultured primary human fibroblasts
Scientific Reports (2020)